eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
Share:
Send email
Share:
Original paper

Enhancers of cancer stem cells and epithelial–mesenchymal transition: Lin28, MUC1, and lipocalin-2 as a new prognostic axis in classical invasive lobular carcinoma of the breast

Mohamed Ali Alabiad
1, 2
,
Raja Aljafil
3
,
Amany Mohamed Shalaby
4
,
Ahmed M. Yehia
5
,
Mohammed Alorini
6
,
Basma Hamed Ibrahim
1

  1. Department of Pathology, Faculty of Medicine, Zagazig University, Zagazig, Egypt
  2. Department of Pathology, General Medicine Practice program, Batterjee Medical College, Aseer, Saudi Arabia
  3. Department of Pathology, Faculty of Medicine, University of Benghazi, Benghazi, Libya
  4. Department of Histology and Cell Biology, Faculty of Medicine, Tanta University, Tanta, Egypt
  5. Department of General Surgery, Faculty of Medicine, Zagazig University, Zagazig, Egypt
  6. Department of Pathology, College of Medicine, Qassim University, Unaizah, Kingdom of Saudi Arabia
Pol J Pathol 2024; 75 (4):
DOI: https://doi.org/10.5114/pjp.2024.145812
Online publish date: 2024/12/10
Article file
- Enhancers of cancer.pdf  [8.65 MB]
Get citation
 
PlumX metrics:
 
1. Dossus L, Benusiglio PR. Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Res 2015; 17: 37. DOI: 10.1186/s13058-015-0546-7.
2. Jørgensen CLT, Forsare C, Bendahl PO, et al. Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression. Breast Cancer Res Treat 2020; 181: 369-381.
3. Gooding AJ, Schiemann WP Epithelial–Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: mediators of Breast Cancer Therapy Resistance EMT Programs and CSC Chemoresistance. Mol Cancer Res 2020; 18: 1257-1270.
4. Chebouti I, Blassl C, Wimberger P, et al. Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis? Oncotarget 2016; 7: 26454-26464.
5. Peng F, Li TT, Wang KL, et al. H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance. Cell Death Dis 2017; 8: e2569. DOI: 10.1038/cddis.2016.438.
6. Yamashita N, Kufe D. Addiction of cancer stem cells to MUC1-C in triple-negative breast cancer progression. Int J Mol Sci 2022; 23: 8219. DOI: 10.3390/ijms23158219.
7. Wang YP, Yu GR, Lee MJ, et al. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepa­tocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway. Hepatology 2013; 58: 1349-1361.
8. Green F, Page D, Fleming I, et al. (eds.). AJCC Cancer Staging Manual. Sixth Edition. Philadelphia: Springer Science+; 2002.
9. Alabiad MA, Elderey MS, Shalaby AM, et al. The usefulness of 4 immunoperoxidase stains applied to urinary cytology samples in the pathologic stage of urothelial carcinoma: a study with histologic correlation. Appl Immunohistochem Mol Morphol 2021; 29: 422-432.
10. Alabiad M, Harb O, Mandour D, et al. Prognostic and clinicopathological implications of expression of Beclin-1 and hypoxia-inducible factor 1 in serous ovarian carcinoma: an immunohistochemical study. Pol J Pathol 2021; 72: 23-38.
11. Shalaby AM, Aboregela AM, Alabiad MA, et al. The effect of induced diabetes mellitus on the cerebellar cortex of adult male rat and the possible protective role of oxymatrine: a histological, immunohistochemical and biochemical study. Ultrastruct Pathol 2021; 45: 182-196.
12. Shalaby AM, Alnasser SM, Khairy DA, et al. The neuroprotective effect of ginsenoside Rb1 on the cerebral cortex changes induced by aluminium chloride in a mouse model of Alzheimer’s disease: a histological, immunohistochemical, and biochemical study. J Chem Neuroanat 2023; 129: 102248. DOI: 10.1016/j.jchemneu.2023.102248.
13. Shalaby AM, Sharaf Eldin HE, Abdelsameea AA, et al. Betahistine attenuates seizures, neurodegeneration, apoptosis, and gliosis in the cerebral cortex and hippocampus in a mouse model of epilepsy: a histological, immunohistochemical, and biochemical study. Microsc Microanal 2022; 28: 1734-1748.
14. Alabiad MA, Harb OA, Abozaid M, et al. The diagnostic and prognostic roles of combined expression of novel biomarkers in lung adenocarcinoma and lung squamous cell carcinoma: an immunohistochemical study. Iran J Pathol 2021; 16: 162-173.
15. Khayal EES, Alabiad MA, Elkholy MR, et al. The immune modulatory role of marjoram extract on imidacloprid induced toxic effects in thymus and spleen of adult rats. Toxicology 2022; 471: 153174. DOI: 10.1016/j.tox.2022.153174.
16. Tawfeek SE, Shalaby AM, Alabiad MA, et al. Metanil yellow promotes oxidative stress, astrogliosis, and apoptosis in the cerebellar cortex of adult male rat with possible protective effect of scutellarin: a histological and immunohistochemical study. Tissue Cell 2021; 73: 101624. DOI: 10.1016/j.tice.2021.101624.
17. Ahmed MM, Gebriel MG, Morad EA, et al. Expression of immune checkpoint regulators, cytotoxic T-lymphocyte antigen-4, and programmed death-ligand 1 in Epstein-Barr virus-associated nasopharyngeal carcinoma. Appl Immunohistochem Mol Morphol 2021; 29: 401-408.
18. Alabiad MA, Harb OA, Taha HF, et al. Prognostic and clinic-pathological significances of SCF and COX-2 expression in inflammatory and malignant prostatic lesions. Pathol Oncol Res 2019; 25: 611-624.
19. Shalaby AM, Albakkosh AM, Shalaby RH, et al. Lemongrass essential oil attenuates perfluorooctane sulfonate-induced jejunal mucosal injury in rat: a histological, immunohistochemical, and biochemical study. Microsc Microanal 2023; 29: 841-857.
20. Alabiad MA, Harb OA, Hefzi N, et al. Prognostic and clinicopathological significance of TMEFF2, SMOC-2, and SOX17 expression in endometrial carcinoma. Exp Mol Pathol 2021; 122: 104670. DOI: 10.1016/j.yexmp.2021.104670.
21. Elsalam SA, Mansor AE, Sarhan MH, et al. Evaluation of apoptosis, proliferation, and adhesion molecule expression in trophoblastic tissue of women with recurrent spontaneous abortion and infected with Toxoplasma gondii. Int J Gynecol Pathol 2021; 40: 124-133.
22. Elshamy AM, Salem OM, Safa MA, et al. Possible protective effects of CO Q10 against vincristine-induced peripheral neuropathy: targeting oxidative stress, inflammation, and sarmoptosis. J Biochem Mol Toxicol 2022; 36: e22976. DOI: 10.1002/jbt.22976.
23. Elsheikh AA, Alnasser SM, Shalaby AM, et al. Polystyrene microplastic particles induced hepatotoxic injury via pyroptosis, oxidative stress, and fibrotic changes in adult male albino rats; the therapeutic role of silymarin. Toxicol Mech Methods 2023; 33: 512-528.
24. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580.
25. Sa-Nguanraksa D, Pongthong W, Samarnthai N, et al. Expression of androgen receptor and its regulatory molecule Lin28 in non-luminal subtype breast cancer. Mol Clin Oncol 2020; 12: 511-518.
26. Sinn B, Von Minckwitz G, Denkert C, et al. Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer. Ann Oncol 2013; 24: 2316-2324.
27. Ören B, Urosevic J, Mertens C, et al. Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis. J Pathol 2016; 239: 274-285.
28. Yu J, Bhargava R, Dabbs DJ. Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies. Diagn Pathol 2010; 5: 36. DOI: 10.1186/1746-1596-5-36.
29. Aktas B, Tewes M, Fehm T, et al. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res 2009; 11: R46. DOI: 10.1186/bcr2333.
30. Gnemmi V, Bouillez A, Gaudelot K, et al. MUC1 drives epithelial–mesenchymal transition in renal carcinoma through Wnt/-catenin pathway and interaction with SNAIL promoter. Cancer Lett 2014; 346: 225-236.
31. Guo M, Luo B, Pan M, et al. MUC1 plays an essential role in tumor immunity of colorectal cancer stem cell vaccine. Int Immunopharmacol 2020; 85: 106631. DOI: 10.1016/j.intimp.2020.106631.
32. Xiong H, Zhao W, Wang J, et al. Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities. Oncotarget 2017; 8: 25721-25735.
33. Xie R, Wang Y, Nie W, et al. Lin28B expression correlates with aggressive clinicopathological characteristics in breast invasive ductal carcinoma. Cancer Biother Radiopharm 2014; 29: 215-220.
34. Xu C, Jin S, Huang L. Expression of Lin28 is correlated with prognosis and expression of HER-2 and steroid receptors in breast cancer. Onco Targets Ther 2019; 12: 1105-1110.
35. Xie R, Wang Y, Nie W, et al. Lin28B expression correlates with aggressive clinicopathological characteristics in breast invasive ductal carcinoma. Cancer Biother Radiopharm 2014; 29: 215-220.
36. Shen H, Yang Y, Zhao L, et al. Lin28A and androgen receptor expression in ER–/Her2+ breast cancer. Breast Cancer Res Treat 2016; 156: 135-147.
37. Croce MV, Isla-Larrain MT, Rua CE, et al. Patterns of MUC1 tissue expression defined by an anti-MUC1 cytoplasmic tail monoclonal antibody in breast cancer. J Histochem Cytochem 2003; 51: 781-788.
38. Jing X, Liang H, Hao C, et al. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer. Oncol Rep 2019; 41: 801-810.
39. McGuckin MA, Walsh MD, Hohn BG, et al. Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum Pathol 1995; 26: 432-439.
40. Atta Manu E, Bedu-Addo K, Titiloye N, et al. Expression of tumour-associated MUC1 is a poor prognostic marker in breast cancer in Kumasi, Ghana. J Oncol 2020; 2020: 9752952. DOI: 10.1155/2020/9752952.
41. Stergiou N, Nagel J, Pektor S, et al. Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer. Int J Med Sci 2019; 16: 1188-1198.
42. Chang E, Lee E, Yoo C, et al. Cellular localization of MUC1 in benign and malignant breast lesions with the histological correlation and the prognostic significance. J Breast Cancer 2005; 8: 150-156.
43. Chu JS, Chang KJ. Mucin expression in mucinous carcinoma and other invasive carcinomas of the breast. Cancer Lett 1999; 142: 121-127.
44. Rakha EA, Boyce RWG, Abd El-Rehim D, et al. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol 2005; 18: 1295-1304.
45. Taylor-Papadimitriou J, Burchell J, Miles D, et al. MUC1 and cancer. Biochim Biophys Acta 1999; 1455: 301-313.
46. Nishimura S, Yamamoto Y, Sugimoto A, et al. Lipocalin-2 negatively regulates epithelial–mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer. Gastric Cancer 2022; 25: 850-861.
47. Celepli P, Bigat İ, Karabulut S, et al. Evaluation of Lipocalin-2 and Twist expression in thyroid cancers and its relationship with epithelial mesenchymal transition. Ann Diagn Pathol 2022; 59: 151973. DOI: 10.1016/j.anndiagpath.2022.151973.
48. Kurozumi S, Alsaeed S, Orah N, et al. Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer. Breast Cancer Res Treat 2020; 179: 557-564.
49. Villodre ES, Hu X, Larson R, et al. Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Mol Oncol 2021; 15: 2752-2765.
50. Bauer M, Eickhoff JC, Gould MN, et al. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat 2008; 108: 389-397.
Copyright: © 2024 Polish Association of Pathologists and the Polish Branch of the International Academy of Pathology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.